33 results on '"Dopazo A"'
Search Results
2. LIVER TRANSPLANTATION WITH NEOADJUVANT CHEMORADIATION FOR TREATMENT OF UNRESECTABLE HILAR CHOLANGIOCARCINOMA. AN EUROPEAN SERIES.
3. TREATMENT OF ANTIBODY MEDIATED REJECTION AFTER LIVER TRANSPLANT: WHAT DO WE KNOW?
4. Impact of Recipient Age on Long-Term after Liver Transplantation: A Double Propensity Score Matching Analysis
5. LIVER TRANSPLANTATION WITH NEOADJUVANT CHEMORADIATION FOR TREATMENT OF UNRESECTABLE HILAR CHOLANGIOCARCINOMA. AN EUROPEAN SERIES
6. TREATMENT OF ANTIBODY MEDIATED REJECTION AFTER LIVER TRANSPLANT: WHAT DO WE KNOW?
7. HIGH INTRAPATIENT VARIABILITY OF TACROLIMUS EXPOSURE AFTER LIVER TRANSPLANTATION AS NEW MARKER OF POOR OUTCOMES
8. Biliary Dilatation and Strictures After Composite Liver–Small Bowel Transplantation in Children: Defining a Newly Recognized Complication
9. Impact of Recipient Age on Long-Term after Liver Transplantation
10. Combined liver-intestine grafts compared with isolated intestinal transplantation in children: a single-center experience
11. Sequelae of Ischaemia-Reperfusion Injury in Intestinal Transplantation
12. Benefit of Treating Hepatocellular Carcinoma Recurrence After Liver Transplantion.
13. Sequelae of Ischaemia-Reperfusion Injury in Intestinal Transplantation.
14. Benefit of Treating Hepatocellular Carcinoma Recurrence After Liver Transplantion
15. SAFE CONVERSION TO MYCOPHENOLATE MOFETIL IN STABLE LIVER TRANSPLANTED PATIENTS WITH TOXICITY SECONDARY TO ANTICALCINEURINICS
16. Combined Liver-Intestine Grafts Compared With Isolated Intestinal Transplantation in Children
17. Biliary Dilatation and Strictures After Composite Liver–Small Bowel Transplantation in Children: Defining a Newly Recognized Complication
18. DE NOVO MALIGNANCIES AFTER LIVER TRANSPLANTATION
19. USE OF LIVER GRAFTS FROM DONORS OLDER THAN 70 YEARS IN RECIPIENTS WITH CHRONIC HCV
20. DE NOVO MALIGNANCIES AFTER LIVER TRANSPLANTATION
21. USE OF LIVER GRAFTS FROM DONORS OLDER THAN 70 YEARS IN RECIPIENTS WITH CHRONIC HCV
22. SAFE CONVERSION TO MYCOPHENOLATE MOFETIL IN STABLE LIVER TRANSPLANTED PATIENTS WITH TOXICITY SECONDARY TO ANTICALCINEURINICS
23. Early and Late Indications of Everolimus after Liver Transplantation.
24. Obesity and Metabolic Syndrome after Liver Transplantation.
25. Post-Transplant Long Term Management of Patients with Pre-Liver Transplantation Renal Insuficiency.
26. Potencial Antifbibrotic Effect of Long-Term Everolimus Based Immunosuppression in HCV Positive Liver Transplant Patients.
27. ANALYSIS OF METABOLIC CHANGES AT REPERFUSION IN CHILDREN UNDERGOING INTESTINAL TRANSPLANTATION.
28. APPLICATION OF THE BCLC STAGING SYSTEM FOR PATIENTS FOR WITH HEPATOCELLULAR CARCINOMA (HCC) BEFORE 1999. DOES IT AFFECT PROGNOSIS?
29. EVOLUTION AND MANAGEMENT OF DE NOVO NEOPLASMS POST-LIVER TRANSPLANTATION. A 20-YEAR EXPERIENCE FROM A SINGLE EUROPEAN CENTRE.
30. RISK FACTORS FOR EARLY MORTALITY FOLLOWING INTESTINAL TRANSPLANTATION IN CHILDREN. MULTIVARIATE ANALYSIS.
31. ELDERLY DONORS COULD BE GOOD LIVER DONORS.
32. LIVER TRANSPLANTATION IN HIV-HCV CO-INFECTED PATIENTS.
33. LIVER TRANSPLANTATION IN PATIENTS OLDER THAN 65 YEARS OLD.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.